focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 11,500.00
Ask: 12,470.00
Change: 0.00 (0.00%)
Spread: 970.00 (8.435%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

Mon, 30th Nov 2020 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

UBS RAISES ASTRAZENECA TO 'NEUTRAL' (SELL) - PRICE TARGET 7,500 (7,300) PENCE

----------

BARCLAYS RAISES UNILEVER PRICE TARGET TO 5,500 (5,420) PENCE - 'OVERWEIGHT'

----------

UBS RAISES MELROSE INDUSTRIES PRICE TARGET TO 185 (134) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES WHITBREAD TARGET TO 3,000 (2,700) PENCE - 'EQUAL-WEIGHT'

----------

BARCLAYS RAISES SPIRAX-SARCO PRICE TARGET TO 9,925 (9,380) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES NEXT PRICE TARGET TO 7,000 (6,500) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES ASSOCIATED BRITISH FOODS PRICE TARGET TO 2,300 (2,100) PENCE - 'OUTPERFORM'

----------

RBC RAISES ANTOFAGASTA PRICE TARGET TO 1,080 (780) PENCE - 'UNDERPERFORM'

----------

RBC RAISES RIO TINTO PRICE TARGET TO 5,900 (5,000) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES BHP GROUP PRICE TARGET TO 2,400 (2,000) PENCE - 'OUTPERFORM'

----------

RBC RAISES GLENCORE PRICE TARGET TO 280 (240) PENCE - 'OUTPERFORM'

----------

RBC RAISES ANGLO AMERICAN PRICE TARGET TO 3,400 (2,400) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS AVEVA GROUP PRICE TARGET TO 3,600 (4,011) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES STANDARD LIFE ABERDEEN PRICE TARGET TO 298 (260) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES SCHRODERS PRICE TARGET TO 2,465 (2,195) PENCE - 'SELL'

----------

JEFFERIES RAISES AVIVA PRICE TARGET TO 400 (350) PENCE - 'BUY'

----------

BANK OF AMERICA RAISES AVIVA PRICE TARGET TO 375 (360) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES OCADO PRICE TARGET TO 2,000 (1,800) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

RBC RAISES DUNELM GROUP TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1,450 PENCE

----------

RBC RAISES MARKS & SPENCER PRICE TARGET TO 145 (120) PENCE - 'OUTPERFORM'

----------

MORGAN STANLEY RAISES BEAZLEY PRICE TARGET TO 390 (350) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES LANCASHIRE PRICE TARGET TO 1,065 (1,045) P - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES HISCOX PRICE TARGET TO 1450 (990) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES VESUVIUS PRICE TARGET TO 500 (400) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS CARNIVAL PRICE TARGET TO 1,725 (2,250) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES MAN GROUP PRICE TARGET TO 140 (135) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES ASHMORE GROUP PRICE TARGET TO 435 (420) PENCE - 'BUY'

----------

JPMORGAN CUTS BODYCOTE TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 635 (670) PENCE

----------

BARCLAYS RAISES BODYCOTE PRICE TARGET TO 715 (620) PENCE - 'EQUAL WEIGHT'

----------

JPMORGAN RAISES MITCHELLS & BUTLERS TARGET TO 360 (340) PENCE - 'OVERWEIGHT'

----------

BANK OF AMERICA RAISES BALFOUR BEATTY PRICE TARGET TO 350 (345) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

UBS RAISES KINGSPAN GROUP PRICE TARGET TO 60 (55) EUR - 'SELL'

----------

BERENBERG RAISES VICTORIA PRICE TARGET TO 770 (330) PENCE - 'BUY'

----------

BARCLAYS CUTS NEWRIVER REIT PRICE TARGET TO 72 (76) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES CENTRAL ASIA METALS TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 270 (170) PENCE

----------

RBC RAISES ANGLO PACIFIC GROUP PRICE TARGET TO 205 (195) PENCE - 'OUTPERFORM'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.